Alere Receives FDA Clearance for Modified Influenza A & B Test

NEW YORK (360Dx) – The US Food and Drug Administration has issued 510(k) clearance for the Alere i Influenza A & B panel, Alere i Influenza A & B control swab kit, and the Alere i instrument.

The agency late last month issued the clearance, which allows Alere to market the device in the US.